Replies to post #92539 on Biotech Values

[DewDiligence]

…no wonder others are jumping on the NS5A bandwagon

Inasmuch as the HCV polymerase is also known as NS5B, combining an NS5A inhibitor such as BMS-790052 with a polymerase inhibitor is tantamount to taking one item from column A and one item from column B—just like in a Chinese restaurant :- )

[DewDiligence]

Presidio to present preclinical NS5A data at EASL:

http://finance.yahoo.com/news/Presidio-Pharmaceuticals-Inc-bw-4263771663.html?x=0&.v=1

This drug candidate, previously unnamed, is now called PPI-461. Presidio acquired the compound from XTL Biopharmaceuticals’ back burner in Mar 2008 (#msg-27791536).

I suspect that Presidio is bringing PPI-461 out of the woodwork now to capitalize on the recent buzz about BMS-790052 (#msg-47876219).